Predictors of Aorto-Saphenous Vein Bypass Narrowing Late After Coronary Artery Bypass Grafting

American Journal of Cardiology

Volumn 100, Issue 4, 2007, Pages 640-645

  Rodés Cabau, Josep ^a   Facta, Alvaro ^a   Larose, Eric ^a   DeLarochellière, Robert ^a   Déry, Jean Pierre ^a   Nguyen, Can Manh ^a   Roy, Louis ^a   Proulx, Guy ^a   Gleeton, Onil ^a   Barbeau, Gérald ^a   Noël, Bernard ^a   Rouleau, Jacques ^a   Boudreault, Jean Roch ^a   Bertrand, Olivier F ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAPHENOUS VEIN; STENOSIS; VEIN BYPASS;

AGED; AORTA, THORACIC; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY STENOSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; SEVERITY OF ILLNESS INDEX;

EID: 34547673494     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.080     Document Type: Article

References (12)

1. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336 (1997) 153-162
2. Chen L., Théroux P., Lespérance J., Shabani F., Thibault B., and De Guise P. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol 15 (1996) 1493-1499
3. Keely E.C., Velez C.A., O'Neill W., and Safian R.D. Long-term clinical outcome and predictors of major adverse cardiac events afer percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 38 (2001) 659-665
4. Mehta R.H., Honeycutt E., Shaw L.K., Glower D., Harrington R.A., and Sketch M.H. Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts. Am Heart J 152 (2006) 801-806
5. Domanski M.J., Borkowf C.B., Campeau L., Knatterud G.L., White C., Hoogwerf B., Rosenberg Y., and Geller N.L. Prognostic factors for atherosclerosis progression in saphenous vein grafts. J Am Coll Cardiol 36 (2000) 1877-1883
6. Knatterud G.L., White C., Geller N.L., Campeau L., Forman S.A., Domanski M., Forrester J.S., Gobel F.L., Herd A., Hickey A., et al. Angiographic changes in saphenous vein grafts are predictors of clinical outcomes. Am Heart J 145 (2003) 262-269
7. Ellis S.G., Brener S.J., DeLuca S., Tuzcu M., Raymond R.E., Whitlow P.L., and Topol E. Late myocardial ischemic events after saphenous vein graft intervention: importance of initially "nonsignificant" vein graft lesions. Am J Cardiol 79 (1997) 1460-1464
8. Le May M.R., Labinaz M., Marquis J.F., Laramée L.A., O'Brien E.R., Williams W.L., Jelley J.L., Woodend K., and Higginson L.A. Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol 83 (1999) 681-686
9. Libby P. Managing the risk of atherosclerosis: the role of high-density lipoprotein. Am J Cardiol 88 suppl (2001) 3N-8N
10. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62 (1977) 707-714
11. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sortie P.D., Catellier D., and Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoprotein A-1 and B, and HDL density subfractions. Circulation 104 (2001) 1108-1113
12. Neitzel G, Barboriak J, Pintar K, Qureshi I. Atherosclerosis in aortocoronary bypass grafts: morphological study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis 1986;594-600.